| Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study JR Teerlink, M Metra, GM Felker, P Ponikowski, AA Voors, BD Weatherley, ... The Lancet 373 (9673), 1429-1439, 2009 | 511 | 2009 |
| Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel … SJ Shah, JEA Blair, GS Filippatos, C Macarie, W Ruzyllo, J Korewicki, ... American heart journal 157 (6), 1035-1041, 2009 | 158 | 2009 |
| The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with … P Charron, PM Elliott, JR Gimeno, ALP Caforio, JP Kaski, L Tavazzi, ... European heart journal 39 (20), 1784-1793, 2018 | 132 | 2018 |
| In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients N Sylvius, ZT Bilinska, JP Veinot, A Fidzianska, PM Bolongo, S Poon, ... Journal of medical genetics 42 (8), 639-647, 2005 | 115 | 2005 |
| Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption P Gupta, ZT Bilinska, N Sylvius, E Boudreau, JP Veinot, S Labib, ... Basic research in cardiology 105, 365-377, 2010 | 100 | 2010 |
| Meta-analysis of the prognostic role of late gadolinium enhancement and global systolic impairment in left ventricular noncompaction C Grigoratos, A Barison, A Ivanov, D Andreini, MS Amzulescu, ... JACC: Cardiovascular Imaging 12 (11 Part 1), 2141-2151, 2019 | 99 | 2019 |
| Titin truncating variants in dilated cardiomyopathy–prevalence and genotype-phenotype correlations M Franaszczyk, P Chmielewski, G Truszkowska, P Stawinski, E Michalak, ... PLoS One 12 (1), e0169007, 2017 | 84 | 2017 |
| The BAG3 gene variants in Polish patients with dilated cardiomyopathy: four novel mutations and a genotype-phenotype correlation M Franaszczyk, ZT Bilinska, M Sobieszczańska-Małek, E Michalak, ... Journal of translational medicine 12, 1-8, 2014 | 76 | 2014 |
| Determinants of prognosis in nonischemic dilated cardiomyopathy J Grzybowski, ZT Bilińska, W Rużyłło, W Kupść, E Michalak, ... Journal of cardiac failure 2 (2), 77-85, 1996 | 68 | 1996 |
| Next-generation sequencing for diagnosis of thoracic aortic aneurysms and dissections: diagnostic yield, novel mutations and genotype phenotype correlations JK Poninska, ZT Bilinska, M Franaszczyk, E Michalak, M Rydzanicz, ... Journal of Translational Medicine 14, 1-17, 2016 | 61 | 2016 |
| A Phase 2a dose‐escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS‐986231 in hospitalized patients with heart failure with reduced … C Tita, EM Gilbert, AB Van Bakel, J Grzybowski, GJ Haas, M Jarrah, ... European journal of heart failure 19 (10), 1321-1332, 2017 | 56 | 2017 |
| Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc … S Verma, NK Dhingra, J Butler, SD Anker, JP Ferreira, G Filippatos, ... The Lancet Diabetes & Endocrinology 10 (1), 35-45, 2022 | 40 | 2022 |
| Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fraction M Gheorghiade, SJ Greene, P Ponikowski, AP Maggioni, J Korewicki, ... European journal of heart failure 15 (6), 679-689, 2013 | 35 | 2013 |
| A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous … GT Truszkowska, ZT Bilińska, J Kosińska, J Śleszycka, M Rydzanicz, ... BMC medical genetics 16, 1-9, 2015 | 32 | 2015 |
| Circulating biomarkers of hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy assessed by cardiac magnetic resonance M Gawor, M Śpiewak, A Kubik, A Wróbel, A Lutyńska, M Marczak, ... Biomarkers 23 (7), 676-682, 2018 | 27 | 2018 |
| Obliteration of cardiomyocyte nuclear architecture in a patient with LMNA gene mutation A Fidziańska, ZT Bilińska, F Tesson, T Wagner, M Walski, J Grzybowski, ... Journal of the neurological sciences 271 (1-2), 91-96, 2008 | 27 | 2008 |
| Original articles Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy A Pączkowska, M Szperl, ŁA Małek, Ł Mazurkiewicz, E Skóra, ... Polish Heart Journal (Kardiologia Polska) 67 (3), 235-241, 2009 | 24 | 2009 |
| Orginal article Assessment of the inflammatory process by endomyocardial biopsy in patients with dilated cardiomyopathy based on pathological and immunohistochemical methods M Prochorec-Sobieszek, Z Bilińska, J Grzybowski, Ł Mazurkiewicz, ... Kardiologia Polska (Polish Heart Journal) 64 (5), 479-487, 2006 | 20 | 2006 |
| The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy M Gawor, M Śpiewak, J Janas, K Kożuch, A Wróbel, Ł Mazurkiewicz, ... Kardiologia Polska (Polish Heart Journal) 75 (10), 997-1004, 2017 | 19 | 2017 |
| Restrictive cardiomyopathy due to novel desmin gene mutation N Ojrzyńska, ZT Bilińska, M Franaszczyk, R Płoski, J Grzybowski Kardiologia Polska (Polish Heart Journal) 75 (7), 723-723, 2017 | 17 | 2017 |
